Prepaid Expenses and Other Current Assets

12 Months Ended

Dec. 31, 2022

Prepaid Expense and Other Assets, Current [Abstract]

Prepaid Expenses and Other Current Assets

4.Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	December 31,		December 31,
	2022		2021
Prepaid expenses	$	2,723	$	3,372
Prepaid clinical		6,353		328
Other		782		517
Total prepaid expenses and other current assets	$	9,858	$	4,217

The Company incurred a $0.3 million charge to sales and marketing expense related to the write-downs of DEXYCU sample units associated with expiration of DEXYCU sample units for the year ended December 31, 2022. In connection with the change in CMS reimbursement rules on November 1, 2022 (see Note 6), the Company recorded impairment charges of $0.1 million to cost of sales, excluding amortization of acquired intangible assets, associated with the write-off of excess DEXYCU units, and $0.1 million to sales and marketing expense, associated with the write-off of excess DEXYCU sample units, respectively, whose prepaid manufacturing levels were higher than the Company’s updated forecasts of future demand for those units.